---
schema_version: "secwatch.filing_event.v1"
accession: "0001826466-24-000131"
form_type: "8-K"
ticker: "NIKA"
cik: "0001145604"
company_name: "NIKA PHARMACEUTICALS, INC"
filed_at: "2024-10-16T23:59:59+00:00"
generated_at: "2026-05-30T13:36:04.254882+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Nika Pharmaceuticals dismisses accountant OLAYINKA OYEBOLA & CO, appoints Boladale Lawal & Co

## Summary
- Terminated OLAYINKA OYEBOLA & CO on Oct 2, 2024 after a discovery prompting reconsideration.
- No services were performed by the prior accountant before termination.
- Engaged Boladale Lawal & Co as independent auditor on Oct 5, 2024 to audit financial statements.
- Exhibit 23.1 includes dismissal consent from the former accountant.

## SEC filing metadata
- accession: 0001826466-24-000131
- form_type: 8-K
- ticker: NIKA
- cik: 0001145604
- company_name: NIKA PHARMACEUTICALS, INC
- filed_at: 2024-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000131/0001826466-24-000131-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000131/form-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001826466-24-000131
- JSON: https://secwatch.observer/filing/0001826466-24-000131.json
- Plain text: https://secwatch.observer/filing/0001826466-24-000131.txt

## Key facts
- Auditor Changes
  NIKA PHARMACEUTICALS, INC dismissed OLAYINKA OYEBOLA & CO (Chartered Accountants) as its auditor.
  - Action: dismissal
  - Auditor: OLAYINKA OYEBOLA & CO (Chartered Accountants)
  - Successor: Boladale Lawal & Co (Chartered Accountants)
  source text: nder the Exchange Act (17 CFR 240.13e -4(c)) Section 4 - Matters Related to Accountants and Financial Statements Item 4.01 Changes in Registrant’s Certifying Accountant. On October 2, 2024, Nika Pharmaceuticals, Inc. made a discovery, which led it to consider that it is in the best interest not to continue its engagement of independent accountant OLAYINKA OYEBOLA & CO (Chartered Accountants). No services had been performed by OLAYINKA OYEBOLA & CO (Chartered Accountants) prior to the termination of the engagement on October 2, 2024. On October 5, 2024, Nika Pharmaceuticals, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000131/0001826466-24-000131-index.htm
- Auditor Changes
  NIKA PHARMACEUTICALS, INC engaged Boladale Lawal & Co (Chartered Accountants) as its auditor.
  - Action: engagement
  - Auditor: Boladale Lawal & Co (Chartered Accountants)
  source text: On October 5, 2024, Nika Pharmaceuticals, Inc. engaged the firm of Boladale Lawal & Co (Chartered Accountants) to serve as the independent accountant to audit the company’s financial statements.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000131/0001826466-24-000131-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.